Schneider, M.; Schäfer, N.; Bode, C.; Borger, V.; Eichhorn, L.; Giordano, F.A.; Güresir, E.; Heimann, M.; Ko, Y.-D.; Lehmann, F.;
et al. Prognostic Value of Preoperative Inflammatory Markers in Melanoma Patients with Brain Metastases. J. Clin. Med. 2021, 10, 634.
https://doi.org/10.3390/jcm10040634
AMA Style
Schneider M, Schäfer N, Bode C, Borger V, Eichhorn L, Giordano FA, Güresir E, Heimann M, Ko Y-D, Lehmann F,
et al. Prognostic Value of Preoperative Inflammatory Markers in Melanoma Patients with Brain Metastases. Journal of Clinical Medicine. 2021; 10(4):634.
https://doi.org/10.3390/jcm10040634
Chicago/Turabian Style
Schneider, Matthias, Niklas Schäfer, Christian Bode, Valeri Borger, Lars Eichhorn, Frank A. Giordano, Erdem Güresir, Muriel Heimann, Yon-Dschun Ko, Felix Lehmann,
and et al. 2021. "Prognostic Value of Preoperative Inflammatory Markers in Melanoma Patients with Brain Metastases" Journal of Clinical Medicine 10, no. 4: 634.
https://doi.org/10.3390/jcm10040634
APA Style
Schneider, M., Schäfer, N., Bode, C., Borger, V., Eichhorn, L., Giordano, F. A., Güresir, E., Heimann, M., Ko, Y. -D., Lehmann, F., Potthoff, A. -L., Radbruch, A., Schaub, C., Schwab, K. S., Weller, J., Vatter, H., Herrlinger, U., Landsberg, J., & Schuss, P.
(2021). Prognostic Value of Preoperative Inflammatory Markers in Melanoma Patients with Brain Metastases. Journal of Clinical Medicine, 10(4), 634.
https://doi.org/10.3390/jcm10040634
